Galleggiante and his colleagues [26] found that the CD133+/CD24+ tumor cells isolated from human renal cell carcinoma tissues possessed the CSCs characteristics such as self-renewal ability and multi-differentiation potential. The gene discussed is PROM1; the disease is renal cell carcinoma.